Skip to content
HeyJared

Precision Signals

Precision Signals is a podcast from the CEO Roundtable on Cancer about decoding biomedical progress: what’s real, what matters, and what’s next. We talk with scientists, regulators, investors, and builders operating across the messy interface of research, healthcare, and policy.

Podcast · By Sean Khozin, MD, MPH · English · Official site

Indexed episodes, last 90 days
3
Latest publication
Aug 27, 2026
Audience
Checking…
Earliest in this view
Jul 6, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest episodes

  1. Episode · Aug 27, 2026

    Peter Kolchinsky, PhD: Ideas That Refuse to Die (opens the original)

    Episode notes · Positive tone

    Read excerpt

    In the latest episode of Precision Signals , Sean Khozin speaks with Peter Kolchinsky, founder and managing partner of RA Capital Management. Peter’s perspective is shaped in part by his experience as the child of Soviet Jewish immigrants. His parents brought him a deep appreciation for education, hard work, entrepreneurship, and the opportunity to improve the systems around us. That mindset has guided his journey from scientist and virologist to biotech investor and institution builder. In this

  2. Episode · Jul 21, 2026

    Thomas Clozel, MD on Building Intelligence that Reads Life (opens the original)

    Episode notes

    Read excerpt

    There is a sentence most physicians are trained never to say. Three words: I don't know. Thomas Clozel learned early — from Valentin Fuster at Mount Sinai — that those three words are not a confession of failure, but the beginning of discovery. Thomas is an oncologist, co-founder, and CEO of Owkin . He trained in Strasbourg, then crossed the Atlantic to work under Fuster in cardiology and alongside Olivier Elemento and Ari Melnick at Weill Cornell in computational biology. Ten years ago, he left

  3. Episode · Jul 6, 2026

    Everything is a Signal: Sahir Ali on Connecting AI, Biology, and Venture Capital (opens the original)

    Episode notes · Positive tone

    Read excerpt

    Sahir Ali’s career defies conventional paths. Trained as an engineer, he worked in quantitative finance, contributed to cancer research, built software companies, and ultimately founded Modi Ventures, where he developed the BioStack investment framework for technology-driven life sciences. In this conversation with Sean Khozin, Sahir explains how systems thinking, mathematics, and first-principles reasoning shaped his approach to investing. They discuss the evolution of artificial intelligence i

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

No verified audience measurement yet.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Precision Signals